Economic sanctions against Iran have not formally targeted health care or access to drugs, but they have indirectly led to serious problems for health services — notably for people with cancer.
Cancer is the third-highest cause of death in Iran, greater than in most other Middle Eastern countries. The Program of Action for Cancer Therapy, established by the International Atomic Energy Agency, evaluated the status of Iran's National Cancer Control Program (NCCP) in 2012. It concluded that the NCCP has substantial deficits in all aspects of care, including prevention, early detection, diagnosis, treatment, palliative care and monitoring technology (M. R. Rouhollahi et al. Arch. Iran Med. 17, 222–231; 2014). There is also a serious shortage of cancer drugs in the nation.
Sanctions disrupt health services and basic nutrition through complications in transportation, reduced imports, and difficulty in transferring hard currencies. There can be no improvement in the status of the NCCP until they are lifted.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Rights and permissions
About this article
Cite this article
Shahabi, S. Sanctions in Iran disrupt cancer care. Nature 520, 157 (2015). https://doi.org/10.1038/520157b
Published:
Issue Date:
DOI: https://doi.org/10.1038/520157b
This article is cited by
-
Addressing the impact of economic sanctions on Iranian drug shortages in the joint comprehensive plan of action: promoting access to medicines and health diplomacy
Globalization and Health (2016)
-
Lift sanctions now to save public health
Nature (2015)
-
Interim initiative for health in Iran
Nature (2015)